Phenoxybenzamine

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive,

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive,

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive,

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive,

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive,

An orally bioavailable, selective inhibitor of PDGFR&alpha, PDGFR&beta, and FLT3 (IC₅₀s = 11, 3.2, and 4 nM, respectively) also inhibits mutant forms of these kinases, including the D842V-containing form of PDGFR and D835Y and internal

DescriptionWe are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product is biorenewable and thus aligns with Safer Solvents and Auxiliaries" and "Use of Renewable"

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the

Application Dronedarone hydrochloride has been used as an anti-arrhythmic drug to assess its impact in P19C5 embryoid bodies (EBs). It has also been used to determine its antiviral potency.

Application Dronedarone hydrochloride has been used as an anti-arrhythmic drug to assess its impact in P19C5 embryoid bodies (EBs). It has also been used to determine its antiviral potency.

Eplerenone is an aldosterone blocker, which particularly blocks mineralocorticoid receptor. It reduces cardiovascular risk in patients following acute myocardial infarction.